Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

    NEXT STORY
    Meticore Reviews – Real Weight Loss Ingredients or Skeptical Results? 2021 Review.com Research
    PREV STORY
    Valneva Announces Amendment to Deerfield and OrbiMed Debt Facility Terms
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    OraSure Announces 2018 Second Quarter Financial Results

    BETHLEHEM, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a ...

    author_avatar
    NASDAQ Market News

    Apricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year 2016 Financial Results Conference Call

    SAN DIEGO, March 09, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Biopharma Leaders Unite to Stand with Science

    author_avatar
    NASDAQ Market News